T4-monotherapy
-
2014 ATA thyroid therapy guidelines: 1. Levothyroxine
In this series of posts, I paraphrase a 2014 thyroid therapy guidelines document in a way that even the brain-fogged hypothyroid patient can understand more quickly and easily than reading the original version. Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine [this post] 2014 ATA Thyroid therapy guidelines: 2. Ethics 2014 ATA…
-
Pharma prejudice refuses a paradigm shift in thyroid therapy
This post engages in a moral argument, not a scientific one. Thyroid pharmaceutical prejudice is part of a paradigm that is refusing to shift. We need to keep asking key questions and fight together for this shift. Look around you today. Thyroid guidelines and health care systems currently treat all thyroid patients as one undifferentiated…
-
Thyroid pharma: Bioidentical yet harmful?
Any fair criticism of a medication’s potential for harm or benefit should first examine the properties of the medication and how it interacts with the human body in general. Next, we should distinguish the content of a pharmaceutical tool from its use (dosing adjustments, circumstances). Then finally, we should consider this: The therapy has to…
-
Part 5: All thyroid meds are bioidentical, but individual response varies widely
This post concludes my response to a misleading video (10). THYROID HORMONE PHARMACEUTICALS A suspicion many people have is that thyroid hormone pharmaceuticals are very different from the thyroid hormones our bodies produce. Let’s look into the claim that they are “bioidentical” in structure and function. Synthetic thyroid hormone has a counter-clockwise rotated molecule (it…